• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Zontivity is going to be BIG

Quote
Pretty funny posts. I actually think the company will hang on for a lot longer than usual with this one. You hear Dervishian at the meeting? The guy and the marketing team are pumped! It's not real, but that's beside the point. We've got 2 full training classes that have just been hired. It's weird, but I think the people at headquarters are so full of themselves they might actually believe we are "on the edge" of something big.

What can you say?
 




My manager just told me yesterday that our group is "right-sized" now and there is a belief that Zontivity will actually pick up.

And even more as analysis starts to be published.

I don't know. I don't think they do.

It sure would be nice to get some real resources though
 




We are on the edge of the cliff. Don't fool yourself thinking Dervishit is not worried about his own job. All the marketing, senior leadership, sales reps, those boxing this manure in the warehouse, and anyone who is tied to this product is in danger of being unemployed very soon. Merck has a tendency of pretending like they are going to start ramping up for something great right before they announce layoffs. By end of month we will hear the same speech about the continued need to be vigilant and make tough decisions for the future of Mother Merck. I can't believe they can say the same speech over and over without laughing. What a joke! Just give me my package before you start taking that away too.
 




worked with marketing team HQ person recently. He says we're "right sized" and in pretty good position.

I can't believe it but that's what she said.

Very difficult sale

Next to impossible
 




Does Zontivity have potential? Is it a good drug? Absolutely! And if you don't think so you should try reading more than the annotated PIand cafe pharma. Will Merck provide the resources and time for Zontivity to be successful? I have no more idea than any other rep...but I hope they do.
 












Here we go again. Opened new weekly data to show nothing but goose eggs-again. What is everybody doing to see this drug? I can't get anyone to use it.

For those who do have doc's using it-are they using it based on information they get online? Because it certainly can't be from the information we're giving them. We don't even know some of the finer details of the study.
 




Anonymous said:
Does Zontivity have potential? Is it a good drug? Absolutely! And if you don't think so you should try reading more than the annotated PIand cafe pharma. Will Merck provide the resources and time for Zontivity to be successful? I have no more idea than any other rep...but I hope they do.
Click to expand...

Tell us why "absolutely." Last I looked there's a whole lot of us who don't have any scripts on the books. After 8 months? Something just isn't right
 




Anonymous said:
Here we go again. Opened new weekly data to show nothing but goose eggs-again. What is everybody doing to see this drug? I can't get anyone to use it.

For those who do have doc's using it-are they using it based on information they get online? Because it certainly can't be from the information we're giving them. We don't even know some of the finer details of the study.
Click to expand...

Where are the most scripts? NE?
 




Anonymous said:
Here we go again. Opened new weekly data to show nothing but goose eggs-again. What is everybody doing to see this drug? I can't get anyone to use it.

For those who do have doc's using it-are they using it based on information they get online? Because it certainly can't be from the information we're giving them. We don't even know some of the finer details of the study.
Click to expand...

Man are you dense, learn to buy the business. You only need one or two physicians to make Presidents Club.
 




I am a former CCR rep in the South and I have a number of cards that have started using the drug. Focus on the patients that have a prior history of MI and multi vessel disease that end up back in the CCL. You have to really sell the PAR mechanism of action to differentiate our drug. I also have cards that do a lot of peripherals in the PAD arena that like our data also. It is not an easy sell but keep it simple and just focus on a few key OAP targets until you get a few to start writing Z.
 




Anonymous said:
Man are you dense, learn to buy the business. You only need one or two physicians to make Presidents Club.
Click to expand...

Buy the business, huh? And why don't you tell us how you do that Einstein, especially when you have limited RFM dollars, and limited access dick wad.

And you need a lot more than 1 or 2 physicians writing to make the VP club know-it-all. 300 scripts by years end...remember that one you slob.
 




Anonymous said:
Buy the business, huh? And why don't you tell us how you do that Einstein, especially when you have limited RFM dollars, and limited access dick wad.

And you need a lot more than 1 or 2 physicians writing to make the VP club know-it-all. 300 scripts by years end...remember that one you slob.
Click to expand...

Apparently, you are an idiot that should not be in sales. Dimwitted ass, three hundred RX's no problem with a well bought pusher. Hopefully you are gone in July.
 




Anonymous said:
Apparently, you are an idiot that should not be in sales. Dimwitted ass, three hundred RX's no problem with a well bought pusher. Hopefully you are gone in July.
Click to expand...

Yes you do need to be creative. I am picking my chosen Doctors kid up at college every Friday and returning him to school every Sunday. A round trip of 400 miles, well worth the effort for the BP Club and the the 5% raise.
 




Anonymous said:
Apparently, you are an idiot that should not be in sales. Dimwitted ass, three hundred RX's no problem with a well bought pusher. Hopefully you are gone in July.
Click to expand...

Such a tough guy. Too bad you don't live next to me. No, I won't be going anywhere in July. Sorry-our group is now "right sized." But maybe it might be your sales group.

A well bought pusher huh? Yeah, go sell appliances or copy machines or cars. Maybe you're the reason why docs don't like us anymore. Too many car salesman in the ranks.
 




Anonymous said:
Such a tough guy. Too bad you don't live next to me. No, I won't be going anywhere in July. Sorry-our group is now "right sized." But maybe it might be your sales group.

A well bought pusher huh? Yeah, go sell appliances or copy machines or cars. Maybe you're the reason why docs don't like us anymore. Too many car salesman in the ranks.
Click to expand...

Just a smart guy! You couldn't sell toilet paper in an outhouse. You are why the company is in the state it is. You are a loser. You are a slacker. You are a useless turd. If you can't stand the fire don't get out of the pot. You will be gone!
 




Hey Dervishian..."I continue to hear great stories of success with our customers with zontivity." Yeah, then why the CYA move with STEM?

Resources? An annotated PI, patient profiles, and a sales aid doest count as a resource. What a frickin joke this has turned out to be. And the managers texting district members about "verbal commits" is a frickin' joke too. If we got half the scripts out of these so called visual commitments things would look a little different-but not a lot.

I've got an idea! Lets get together again at a national meeting and waste an entire day role playing. You dicks are so far removed from reality its a joke. Role playing fantasy discussions with fantasy doctors with what you call "resources" is another frickin' joke. Pull your heads out of the sand.

We have no worth-while resources, hell, we don't even have the trial. We have a drug that's got a 50-60% bleeding profile, we aren't listed in any guidelines and your scratching your ass wondering why this isn't being sold. You all are acting like a bunch of rookies but the only problem is your not.

And don't think STEM is going to help you. You might get some very candid feedback but we all know how that gets whitewashed in the final report. Anonymous? Yeah, right. These guys show up in my territory and I'll set them up big-time in my offices. They will never want to come back.

The drug sucks ass! What else can be said?

But you'll continue to think it's not you-it's us! We have an unbelievable drug with outcomes! Yeah, with a huge downside that none of you seems to understand. By the way, how many of those certified speakers do we have that have written? How many of those were not involved in the trial? That ought to be a starting point for you. But you don't listen. Which is why this exercise will amount to a waste of our time, money, and resources. Oh, that's right. We don't have any of those.
 




I agree with many of the comments expressed in the last post. I have a number of cards now( in the South) writing Z but I feel like we are not getting enough support from the HO. Here are a few of the following areas that I think are hurting the brand and our launch:
1) It has been very difficult to set up MMFs due to a lack of speakers
2) We have not been able to get many of our academic card on board with Z who have attended our national HO programs.
3) $800 dollars a month to launch a brand is problematic.
4) Not enough marketing buzz at sites like The Heart.org at major meetings like ACC.

I do not mean to be negative but we should be in a far better place right now with our luanch. Our market is highly competitive, but we have good enough data to create a niche for this drug in post MI patients with multi vessel disease. The PAD market also has good potential. Let's hope we get more support soon or we could all be in trouble by the summer.
 




Anonymous said:
I agree with many of the comments expressed in the last post. I have a number of cards now( in the South) writing Z but I feel like we are not getting enough support from the HO. Here are a few of the following areas that I think are hurting the brand and our launch:
1) It has been very difficult to set up MMFs due to a lack of speakers
2) We have not been able to get many of our academic card on board with Z who have attended our national HO programs.
3) $800 dollars a month to launch a brand is problematic.
4) Not enough marketing buzz at sites like The Heart.org at major meetings like ACC.

I do not mean to be negative but we should be in a far better place right now with our luanch. Our market is highly competitive, but we have good enough data to create a niche for this drug in post MI patients with multi vessel disease. The PAD market also has good potential. Let's hope we get more support soon or we could all be in trouble by the summer.
Click to expand...

Thank you for your courage and candor. I have focused my attention on the sleep drug as it is going gangbusters. Par one reps suck so get your affairs in order, remember Saphrass?

MD
 




Top Bottom
Back
Quote